Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation
Robin K. Suda(University of Pennsylvania), Robert J. Pignolo(Mayo Clinic), Eileen M. Shore(Fisher & Paykel Healthcare (New Zealand)), Kevin P. Egan(University of Pennsylvania), Paul C. Billings(University of Pennsylvania), David Porter(Texas Oncology), Ruth McCarrick-Walmsley(University of Pennsylvania), Jung‐Hoon Kim(Sogang University), David L. Glaser(University of Pennsylvania)
Cited by 127
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1
|Human Mutation|2008|447
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★
|American Journal of Transplantation|2011|218